Novobiocin
Изглед
| Klinički podaci | |
|---|---|
| Prodajno ime | Albamix, Albamycin, Cardelmycin, Cathocin |
| Drugs.com | Monografija |
| Način primene | Intravenozno |
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 6 h |
| Identifikatori | |
| CAS broj | 303-81-1 |
| ATC kod | None |
| PubChem | CID 9346 |
| DrugBank | DB01051 |
| ChemSpider | 8981 |
| KEGG | C05080 |
| ChEMBL | CHEMBL36506 |
| Hemijski podaci | |
| Formula | C31H36N2O11 |
| Molarna masa | 612,624 |
| |
| |
Novobiocin je organsko jedinjenje, koje sadrži 31 atom ugljenika i ima molekulsku masu od 612,624 Da.[1][2][3][4][5][6][7]
Osobine
[уреди | уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 11 |
| Broj donora vodonika | 5 |
| Broj rotacionih veza | 9 |
| Particioni koeficijent[8] (ALogP) | 3,5 |
| Rastvorljivost[9] (logS, log(mol/L)) | -6,4 |
| Polarna površina[10] (PSA, Å2) | 196,1 |
Reference
[уреди | уреди извор]- ^ Vickers AA, Chopra I, O'neill AJ: Intrinsic novobiocin resistance in Staphylococcus saprophyticus. Antimicrob Agents Chemother. 17;. Vickers, A. A.; Chopra, I.; O'Neill, A. J. (2007 Sep). „Intrinsic novobiocin resistance in Staphylococcus saprophyticus”. Antimicrobial Agents and Chemotherapy. 51 (12): 4484—4485. PMC 2167987
. PMID 17876001. doi:10.1128/AAC.00708-07. Проверите вредност парамет(а)ра за датум: |date=(помоћ) - ^ Burlison JA, Neckers L, Smith AB, Maxwell A, Blagg BS: Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90. J Am Chem Soc. Burlison, J. A.; Neckers, L.; Smith, A. B.; Maxwell, A.; Blagg, B. S. (2006 Dec 6). „Novobiocin: Redesigning a DNA gyrase inhibitor for selective inhibition of hsp90”. Journal of the American Chemical Society. 128 (48): 15529—36. Bibcode:2006JAChS.12815529B. PMID 17132020. doi:10.1021/ja065793p. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Singh G, Jayanarayan KG, Dey CS: Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani. Mol Biochem Parasitol. Singh, G.; Jayanarayan, K. G.; Dey, C. S. (2005 May). „Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani”. Molecular and Biochemical Parasitology. 141 (1): 57—69. PMID 15811527. doi:10.1016/j.molbiopara.2005.01.014. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ CORBIN EE, PRIGOT A: Novobiocin; absorption, diffusion, and excretion studies. Antibiot Annu. 1956-1957;:392-5. CORBIN EE; PRIGOT A (1956). „Novobiocin; absorption, diffusion, and excretion studies”. Antibiotics Annual: 392—395. PMID 13425410.
- ^ DAVID NA, BURGNER PR: Clinical effectiveness and safety of novobiocin. Antibiotic Med Clin Ther. DAVID NA; BURGNER PR (1956 Apr). „Clinical effectiveness and safety of novobiocin”. Antibiotic Medicine & Clinical Therapy (New York, NY). 2 (4): 219—29. PMID 13303117. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889
. PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
- ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.